Clearside Biomedical Inc

NASDAQ:CLSD   1:00:00 PM EDT
1.18
0.00 (0.00%)
: $1.14 -0.04 (-3.39%)
Earnings Announcements

Clearside Biomedical Announces Q3 2022 Financial Results

Published: 11/09/2022 12:48 GMT
Clearside Biomedical Inc (CLSD) - Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update.
Qtrly Loss per Share $0.13.
Q3 Earnings per Share View $-0.03 -- Refinitiv Ibes Data (analyst estimates).
Favorable Safety Results, Durability and Biologic Effect Observed in Cohorts 3 and 4 of Cls-ax Oasis Phase 1/2a Trial.
Revenue is expected to be $0.12 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0.07 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.